Clinical research professionals deeply desire greater diversity among study participants, but correcting underrepresentation of minority populations is not a quick fix. Both immediate interventions and long-term strategies are needed to foster and sustain real change.

Gena Pemberton, Vice President of DEI for Omnicom Health Group, will moderate a panel discussion with patient engagement experts about making changes that really matter to diverse patients.

Join a panel of experts as they discuss:

• DEI learnings from other industries and other areas of health communications can be applied to clinical trial engagement
• DEI barriers overcome in COVID-19 clinical trials
• Large pharma and study sites are approaching inclusivity